Recombinant von Willebrand factor therapy

Recombinant von Willebrand factor (rVWF) therapy is a medical treatment used for people with von Willebrand disease, a condition where blood doesn’t clot properly due to a deficiency or dysfunction of a protein called von Willebrand factor. rVWF is lab-made and designed to replace or supplement the missing or faulty protein, helping blood to clot normally and reducing bleeding episodes. This therapy is effective, safe, and doesn’t require using human plasma, which lowers the risk of infection. It’s administered through injections and is tailored to help manage bleeding symptoms associated with the condition.